Correlation Between Viracta Therapeutics and Surrozen Warrant
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Surrozen Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Surrozen Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Surrozen Warrant, you can compare the effects of market volatilities on Viracta Therapeutics and Surrozen Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Surrozen Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Surrozen Warrant.
Diversification Opportunities for Viracta Therapeutics and Surrozen Warrant
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Viracta and Surrozen is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Surrozen Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen Warrant and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Surrozen Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen Warrant has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Surrozen Warrant go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Surrozen Warrant
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Surrozen Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Viracta Therapeutics is 44.05 times less risky than Surrozen Warrant. The stock trades about -0.18 of its potential returns per unit of risk. The Surrozen Warrant is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 1.50 in Surrozen Warrant on September 2, 2024 and sell it today you would earn a total of 0.47 from holding Surrozen Warrant or generate 31.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 46.88% |
| Values | Daily Returns |
Viracta Therapeutics vs. Surrozen Warrant
Performance |
| Timeline |
| Viracta Therapeutics |
| Surrozen Warrant |
Viracta Therapeutics and Surrozen Warrant Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Surrozen Warrant
The main advantage of trading using opposite Viracta Therapeutics and Surrozen Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Surrozen Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen Warrant will offset losses from the drop in Surrozen Warrant's long position.| Viracta Therapeutics vs. Tff Pharmaceuticals | Viracta Therapeutics vs. Eliem Therapeutics | Viracta Therapeutics vs. Inhibrx | Viracta Therapeutics vs. Enliven Therapeutics |
| Surrozen Warrant vs. Tff Pharmaceuticals | Surrozen Warrant vs. Eliem Therapeutics | Surrozen Warrant vs. Inhibrx | Surrozen Warrant vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |